The role of the Peyer's patch in carcinogenesis. II. 3-Methylcholanthrene-induced lymphoid malignancies in rat Peyer's patches.
To determine whether B or T lymphoid malignancies could be induced following the exposure of lymphoid cells within different lymphoid organs to a potential chemical carcinogen, 3-methylcholanthrene (3-MC) was directly injected into surgically exposed Peyer's patches (PP), mesenteric lymph nodes (MLN), axillary lymph nodes (ALN) or spleens (SP) of Copenhagen rats. A high incidence of lymphoproliferative disorders was observed within rats which received 3-MC injections into the PP, but not in MLN, ALN or SP injected groups of rats. In addition to the PP environment, the dose of 3-MC and exposure to pristane were important factors in the induction of T versus B cell disorders. Whereas the B cell diseases were observed in pristane-treated rats which also received PP injections of low doses (5 or 50 micrograms) of 3-MC, in animals receiving a higher dose (500 micrograms) a much higher incidence of T cell disorders was detected. The observed lymphoproliferative diseases were categorized as B lymphocytic leukemias, B lymphomas or thymic lymphomas on the basis of histological examination of the tissues, white blood cell numbers and differentials, and the morphological and phenotypic characteristics of cell isolates. Abnormal DNA staining characteristics, increased soft agar cloning frequencies and metastasis of the leukemia or tumor cells indicated that malignant cells were associated with the proliferative diseases. Collectively the data indicate that primary lymphoid malignancies of either B or T cell origins may be preferentially and reproducibly induced by localizing low or high doses respectively, of 3-MC within the PP of rats exposed to pristane. These results suggest that PP may have a possible role in the carcinogenesis of lymphocytes following the exposure to chemical carcinogens via the gastrointestinal tract.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D007945:Leukemia, Lymphoid / Q000139:chemically induced / Q000473:pathology; D007958:Leukocyte Count; D008198:Lymph Nodes / Q000187:drug effects; D008223:Lymphoma / Q000139:chemically induced / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000139:chemically induced*; D008748:Methylcholanthrene; D010581:Peyer's Patches / Q000187:drug effects / Q000502:physiology*; D010641:Phenotype; D051381:Rats; D013154:Spleen / Q000187:drug effects; D013953:Thymus Neoplasms / Q000139:chemically induced / Q000473:pathology
D008748:Methylcholanthrene